Isolator

Closed Solicitation Posted

Solicitation number
FDA-RFQ-24-121770
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Jamaica, New York 11433, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration (FDA), New York Laboratory Medical Products (NYLMP) has issued a Request for Quote (RFQ) for the acquisition of one isolator to support sterility testing and analysis. The solicitation is issued for full and open competition under NAICS code 334516 - Analytical Laboratory Instrument Manufacturing. Quotes are due by September 17, 2024 at 10:00 a.m. Eastern Time and must be submitted electronically via email. The Government intends to make a single firm-fixed price award to the responsible offeror submitting the lowest price, technically acceptable quote. The isolator must comply with detailed technical specifications including modularity, bio-decontamination capabilities, data traceability, and integration with analytical equipment. The contractor shall provide installation, qualification, training, warranty, and preventative maintenance services.

This solicitation is not set-aside for any particular business size or type. The place of performance is Jamaica, NY 11433, USA. There are no details provided about any potential incumbent contractors or award value/budget range. The period of performance begins upon contract award and continues for one year from the date of government acceptance.

Notice text

The U.S. Food and Drug Administration (FDA), New York Laboratory Medical Products (NYLMP) has a requirement for an Isolator.

All quotes are due, electronically via email to Nina.Montgomery@fda.hhs.gov no later than September 17, 2024 10:00 a.m. (EST)

Late submissions may not be evaluated.

Files

File Type Posted
RFQ- ISOLATOR 9.11.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity